Latest News
Checked by Medicine.net July 16,2025
On Jul 03, 2025, Norvatis announced results from the Phase III GCAptAIN study evaluating Cosentyx® (secukinumab) in adults with newly diagnosed or relapsing giant cell arteritis (GCA).
ReadMore No More
Spotlights on Medicine.net
Checked by Medicine.net
{{item.publishtime}}
Checked by Medicine.net
{{item.publishtime}}
ReadMore No More
Videos See More
Trusted Data
Patent and Science data platform
Free Experience
Community Center
Free Medicine.net Newsletters
Learn something new every day
Subscribe